Evidence map›Paper›PMID 24280686›Full record

ArticleNature communications2013

RhoB controls coordination of adult angiogenesis and lymphangiogenesis following injury by regulating VEZF1-mediated transcription.

Damien Gerald, Irit Adini, Sharon Shechter, Carole Perruzzi, Joseph Varnau, Benjamin Hopkins, Shiva Kazerounian, Peter Kurschat, Stephanie Blachon, Santosh Khedkar and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Nature communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Liver endothelial cells in NAFLD and transition to NASH and HCC.Cellular and molecular life sciences : CMLS · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 2 countries.

Damien Gerald1] Center for Vascular Biology Research, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA [2] ImClone Systems (a wholly owned subsidiary of Eli Lilly and Company), New York, New York 10016, USA.
Irit Adini
Sharon Shechter
Carole Perruzzi
Joseph Varnau
Benjamin Hopkins
Shiva Kazerounian
Peter Kurschat
Stephanie Blachon
Santosh Khedkar
Mandrita Bagchi
David Sherris
George C Prendergast
Michael Klagsbrun
Heidi Stuhlmann
Alan C Rigby
Janice A Nagy
Laura E Benjamin
Harvard University · USBeth Israel Deaconess Medical Center · USCenter for Vascular Biology Research · USCornell University · USEli Lilly (United States) · USHybrigenics (France) · FRThomas Jefferson University · US

Funding

Microvascular Remodeling in DevelopmentR01HL071049 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI NAGY, JANICE · 2003 to 2011
$3.2M
RhoB Signaling in Cancer Suppression and Cell SuicideR01CA100123 · NCI · LANKENAU INSTITUTE FOR MEDICAL RESEARCH · PI PRENDERGAST, GEORGE C · 2003 to 2007
$1.7M
NCI NIH HHS R01 CA100123NHLBI NIH HHS HL071049NHLBI NIH HHS R01 HL071049
6 · The paper itself

Abstract

Mechanisms governing the distinct temporal dynamics that characterize post-natal angiogenesis and lymphangiogenesis elicited by cutaneous wounds and inflammation remain unclear. RhoB, a stress-induced small GTPase, modulates cellular responses to growth factors, genotoxic stress and neoplastic transformation. Here we show, using RhoB null mice, that loss of RhoB decreases pathological angiogenesis in the ischaemic retina and reduces angiogenesis in response to cutaneous wounding, but enhances lymphangiogenesis following both dermal wounding and inflammatory challenge. We link these unique and opposing roles of RhoB in blood versus lymphatic vasculatures to the RhoB-mediated differential regulation of sprouting and proliferation in primary human blood versus lymphatic endothelial cells. We demonstrate that nuclear RhoB-GTP controls expression of distinct gene sets in each endothelial lineage by regulating VEZF1-mediated transcription. Finally, we identify a small-molecule inhibitor of VEZF1-DNA interaction that recapitulates RhoB loss in ischaemic retinopathy. Our findings establish the first intra-endothelial molecular pathway governing the phased response of angiogenesis and lymphangiogenesis following injury.

Indexed as

LymphangiogenesisNeovascularization, PathologicAnimalsAnimals, NewbornCell LineageDNA-Binding ProteinsEndothelial CellsFemaleGene Expression RegulationInflammationKruppel-Like Transcription FactorsMaleMiceRetinal DiseasesrhoB GTP-Binding ProteinTranscription FactorsDNA-Binding ProteinsKruppel-Like Transcription FactorsrhoB GTP-Binding ProteinTranscription FactorsVezf1 protein, mouse

Identifiers

PMID24280686
PMCPMC3868161
OpenAlexW2090755219

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.